GPLB
Green Planet Bio Engineering Co. Ltd.Company Information
- Company Name
- Green Planet Bio Engineering Co. Ltd.
- CIK
- CIK0001392449
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- GPLB: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- GPLB
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2008-09-30
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 935,000
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- 0.00%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Payable And Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Commitments And Contingencies Disclosure | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Other Liabilities Current | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Stockholders Equity | -1 | -1 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Additional Paid In Capital | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Retained Earnings Accumulated Deficit | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | ||||||
| Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | ||||||
| Common Stock Shares Issued | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | ||||||
| Shares Outstanding | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialGreen Planet Bio Engineering Co. Ltd. (GPLB) — SEC Financial Statements & Analysis
Green Planet Bio Engineering Co. Ltd. (GPLB) is a biological products, (no diagnostic substances) company. Green Planet Bio Engineering Co. Ltd. trades on OTC as: GPLB. Green Planet Bio Engineering Co. Ltd. (GPLB)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, Green Planet Bio Engineering Co. Ltd. carries a market cap of $260.08K, a P/E ratio of -6.23x, a P/B ratio of -0.50x, an enterprise value of $260.08K, and an EV/EBITDA multiple of -6.21x. On profitability, it posts a Return on Equity (ROE) of 8.40%. Per share, it reports EPS of $-0.00, diluted EPS of $-0.00, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 43.16% year-over-year and EPS growth of 43.16% year-over-year. On the balance sheet, it maintains a debt-to-equity ratio of -1.00x, an interest coverage ratio of -279.31x, free cash flow of $-52.90K (TTM), and net debt of $0. Figures sourced from SEC EDGAR.
- Market Cap
- $260.08K
- P/E TTM
- -6.23x
- EPS TTM
- $-0.00
- P/B TTM
- -0.50x
- ROE TTM
- 8.40%
- Debt To Equity
- -1.00x
- Free Cash Flow TTM
- $-52.90K
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Green Planet Bio Engineering Co. Ltd. in?
Green Planet Bio Engineering Co. Ltd. (GPLB) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does GPLB trade on?
Green Planet Bio Engineering Co. Ltd. (GPLB) trades on the OTC.
When was Green Planet Bio Engineering Co. Ltd. (GPLB)'s most recent SEC filing?
Green Planet Bio Engineering Co. Ltd. (GPLB)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is GPLB's market cap?
Green Planet Bio Engineering Co. Ltd. (GPLB) has a market capitalization of $260.08K as of 2026-06-30.
What is GPLB's EPS (earnings per share)?
Green Planet Bio Engineering Co. Ltd. (GPLB)'s trailing twelve month EPS is $-0.00 as of 2026-06-30.
What is GPLB's ROE (return on equity)?
Green Planet Bio Engineering Co. Ltd. (GPLB)'s trailing twelve month Return on Equity (ROE) is 8.40% as of 2026-06-30.
What is GPLB's EV/EBITDA?
Green Planet Bio Engineering Co. Ltd. (GPLB)'s trailing twelve month EV/EBITDA is -6.21x as of 2026-06-30.